Judith Absalon
Datos Biográficos
| ID | 6653473 |
|---|---|
| NOMBRE | Judith Absalon |
| NOMBRES | Judith |
| APELLIDO | Absalon |
| FIRMA | ABSALON J |
| AFILIACIONES | Columbia University |
| ORCID | 0000-0002-1091-520X |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 5 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 5 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2006 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2020 |
| ÍNDICE H | 0 |
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in a worldwide pandemic. Safe and effective vaccines are needed urgently. METHODS: In an ongoing multinational, placebo-controlled, observer-blinded, pivotal efficacy trial, we randomly assigned persons 16 years of age or older in a 1:1 ratio to receive two doses, 21 day…
Gastrointestinal tolerability and quality of life in antiretroviral-naïve HIV-1-infected patients
Most ritonavir-boosted protease inhibitor (PI)-based antiretroviral regimens offer comparable levels of virological efficacy. Thus, the tolerability of the regimen becomes a distinguishing factor with implications for patient quality of life (QoL), treatment adherence, and clinical outcome. This article describes results from the CASTLE study (comparing once-daily atazanavir/ritonavir [ATV/RTV] with twice-daily lopinavir/ritonavir [LPV/RTV], both…
Gender differences in sexual behaviors, sexual partnerships, and HIV among drug users in New York City
Integrating HIV Prevention Activities into the HIV Medical Care Setting
Integrating HIV Prevention Activities into the HIV Medical Care Setting
Sin obras prominentes en esta página.
Gender differences in sexual behaviors, sexual partnerships, and HIV among drug users in New York City
Integrating HIV Prevention Activities into the HIV Medical Care Setting
Integrating HIV Prevention Activities into the HIV Medical Care Setting
Gastrointestinal tolerability and quality of life in antiretroviral-naïve HIV-1-infected patients
Most ritonavir-boosted protease inhibitor (PI)-based antiretroviral regimens offer comparable levels of virological efficacy. Thus, the tolerability of the regimen becomes a distinguishing factor with implications for patient quality of life (QoL), treatment adherence, and clinical outcome. This article describes results from the CASTLE study (comparing once-daily atazanavir/ritonavir [ATV/RTV] with twice-daily lopinavir/ritonavir [LPV/RTV], both…
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in a worldwide pandemic. Safe and effective vaccines are needed urgently. METHODS: In an ongoing multinational, placebo-controlled, observer-blinded, pivotal efficacy trial, we randomly assigned persons 16 years of age or older in a 1:1 ratio to receive two doses, 21 day…
Medicine (5 obras) · HIV/AIDS Research and Interventions (4 obras) · HIV, Drug Use, Sexual Risk (3 obras) · Adolescent Sexual and Reproductive Health (2 obras) · Antiretroviral therapy (2 obras) · Family medicine (2 obras) · Human immunodeficiency virus (HIV (2 obras) · Immunology (2 obras) · Internal Medicine (2 obras) · Viral load (2 obras)